Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

FP, Havers; C, Reed; T, Lim; JM, Montgomery; JD, Klena; AJ, Hall; AM, Fry; DL, Cannon; CF, Chiang; A, Gibbons; I, Krapiunaya; M, Morales-Betoulle; K, Roguski; MAU, Rasheed; B, Freeman; S, Lester; L, Mills; DS, Carroll; SM, Owen; JA, Johnson; V, Semenova; C, Blackmore; D, Blog; SJ, Chai; A, Dunn; J, Hand; S, Jain; S, Lindquist; R, Lynfield; S, Pritchard; T, Sokol; L, Sosa; G, Turabelidze; SM, Watkins; J, Wiesman; RW, Williams; S, Yendell; J, Schiffer; NJ, Thornburg

doi:10.1001/jamainternmed.2020.4130

Public

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

Shared by NobleBlocks on Jul 21, 2020 • 12:00 AM UTC

Authors:

Havers FP

Reed C

Lim T

Abstract

Importance Reported cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection likely underestimate the prevalence of infection in affected communities. Large-scale seroprevalence studies provide better estimates of the proportion of the population previously infected.Objective ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!